Erythrocyte glutathione levels as long-term predictor of transition to psychosis

por Lavoie, S, Berger, M, Schlögelhofer, M, Schäfer, M R, Rice, S, Kim, S-W, Hesse, J, McGorry, P D, Smesny, S, Amminger, G P
Publicado 2017

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids

por Amminger, G P, Mechelli, A, Rice, S, Kim, S-W, Klier, C M, McNamara, R K, Berk, M, McGorry, P D, Schäfer, M R
Publicado 2015

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study

por Berger, M E, Smesny, S, Kim, S-W, Davey, C G, Rice, S, Sarnyai, Z, Schlögelhofer, M, Schäfer, M R, Berk, M, McGorry, P D, Amminger, G P
Publicado 2017

Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers

por Clark, S R, Baune, B T, Schubert, K O, Lavoie, S, Smesny, S, Rice, S M, Schäfer, M R, Benninger, F, Feucht, M, Klier, C M, McGorry, P D, Amminger, G P
Publicado 2016

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis

por Bousman, C A, Yung, A R, Pantelis, C, Ellis, J A, Chavez, R A, Nelson, B, Lin, A, Wood, S J, Amminger, G P, Velakoulis, D, McGorry, P D, Everall, I P, Foley, D L
Publicado 2013

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

por Cotton, S. M., Berk, M., Watson, A., Wood, S., Allott, K., Bartholomeusz, C. F., Bortolasci, C. C., Walder, K., O’Donoghue, B., Dean, O. M., Chanen, A., Amminger, G. P., McGorry, P. D., Burnside, A., Uren, J., Ratheesh, A., Dodd, S.
Publicado 2019

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia

por Di Biase, M A, Zalesky, A, O'keefe, G, Laskaris, L, Baune, B T, Weickert, C S, Olver, J, McGorry, P D, Amminger, G P, Nelson, B, Scott, A M, Hickie, I, Banati, R, Turkheimer, F, Yaqub, M, Everall, I P, Pantelis, C, Cropley, V
Publicado 2017

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical cour...

por Nelson, B., Amminger, G. P., Yuen, H. P., Markulev, C., Lavoie, S., Schäfer, M. R., Hartmann, J. A., Mossaheb, N., Schlögelhofer, M., Smesny, S., Hickie, I. B., Berger, G., Chen, E. Y. H., de Haan, L., Nieman, D. H., Nordentoft, M., Riecher-Rössler, A., Verma, S., Thompson, A., Yung, A. R., McGorry, P. D.
Publicado 2018